Kwang-Seop Song

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: The Green Cross Corporation, Daewoong Pharmaceutical Co., Ltd.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwang-Seop Song. Retrieved from https://idiyas.com/inventor/kwang-seop-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 38(Granted Patents)

Company Filing History:

12 out of 264

The Green Cross Corporation

patents

2 out of 77

Daewoong Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10889574 - Method for producing diphenylmethane derivative (2021-01-12),

2. 10640496 - Method for producing diphenylmethane derivative (2020-05-05),

3. 10294207 - Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same (2019-05-21),

4. 10239873 - 7-azaindole or 4,7-diazaindole derivatives as IKKϵ epsilon and TBK1 inhibitor and pharmaceutical composition comprising same (2019-03-26),

5. 9371303 - Diphenylmethane derivatives as SGLT2 inhibitors (2016-06-21),

6. 9340521 - Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives (2016-05-17),

7. 9006187 - Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same (2015-04-14),

8. 8895558 - Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders (2014-11-25),

9. 8586550 - Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same (2013-11-19),

10. 8541380 - C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same (2013-09-24),

11. 8178551 - Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment (2012-05-15),

12. 7875647 - Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists (2011-01-25),

Title: Kwang-Seop Song: Pioneering Inventor from Yongin-si, South Korea

Introduction: Kwang-Seop Song is a distinguished inventor hailing from Yongin-si, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kwang-Seop Song has recently been granted several patents for his innovative inventions in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Kwang-Seop Song has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the realm of technology. His dedication to innovation has led to the development of cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Kwang-Seop Song has collaborated with top scientists, engineers, and researchers from around the globe, fostering a culture of creativity and knowledge-sharing. His collaborative efforts have resulted in the successful implementation of numerous projects that have had a lasting impact on society.

Conclusion: Kwang-Seop Song's passion for innovation, coupled with his relentless drive to create a better future through technology, has solidified his reputation as a visionary inventor. His work continues to inspire the next generation of innovators and serves as a testament to the power of creativity and perseverance in the world of inventions.

Profile summary based on public USPTO records.